Zobrazeno 1 - 10
of 95
pro vyhledávání: '"G. Girgis"'
Publikováno v:
Veterinary and Animal Science, Vol 24, Iss , Pp 100362- (2024)
A commercial triple-strain Bacillus-based probiotic was tested to determine its effect on the colonization of the ceca by Salmonella Enteritidis (SE) in commercial layer pullets. Two treatments were tested, each with containing 128 day-of-hatch LSL l
Externí odkaz:
https://doaj.org/article/d700c5aa10da4d5a80d685cb3f781765
Publikováno v:
Journal of Applied Poultry Research, Vol 31, Iss 4, Pp 100286- (2022)
SUMMARY: Mitigation of food pathogens such as Salmonella continues to be a focus in poultry production, whether on shell eggs or meat products. No single approach is fully able to eliminate the risk of Salmonella contamination, but rather comprehensi
Externí odkaz:
https://doaj.org/article/024fa19a4d92497aafe7875ce0fad41a
Publikováno v:
Journal of Applied Poultry Research, Vol 31, Iss 2, Pp 100240- (2022)
SUMMARY: Salmonella Enteritidis (SE) has been a major foodborne concern associated with poultry and poultry products. Direct-fed microbials (DFM), such as Bacillus subtilis strains, and mannan-oligosaccharides (MOS) added into poultry feed have emerg
Externí odkaz:
https://doaj.org/article/5b920543a6f147a3a6528c8eebfb31f9
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0232088 (2020)
Salmonella Enteritidis (SE) has been the most common Salmonella serotype associated with foodborne infections in the last several years. Dietary applications of yeast-based preparations in feed have shown to reduce Salmonella colonization in chickens
Externí odkaz:
https://doaj.org/article/4ec76875742042778f3f12fda3e6f0ed
Publikováno v:
Clinical and Translational Science. 16:151-164
This randomized, double-blind, single- and multiple-ascending dose study assessed the pharmacokinetics (PKs), pharmacodynamics, and safety of deucravacitinib (Sotyktu™), a selective and potent small-molecule inhibitor of tyrosine kinase 2, in 100 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be0ec27bb62065a61b01f695666b1c0
https://doi.org/10.1111/cts.13435
https://doi.org/10.1111/cts.13435
Publikováno v:
The Egyptian Journal of Hospital Medicine. 89:7745-7748
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a15f0fefc15dc991f3f1f67c4123e773
https://doi.org/10.21608/ejhm.2022.277132
https://doi.org/10.21608/ejhm.2022.277132
Autor:
Anjaneya, Chimalakonda, Shalabh, Singhal, Raymond, Darbenzio, Randy, Dockens, David, Marchisin, Subhashis, Banerjee, Ihab G, Girgis, John, Throup, Bing, He, Urvi, Aras, Bindu, Murthy
Publikováno v:
Clinical Pharmacology in Drug Development. 11:442-453
Deucravacitinib is a novel, oral, selective inhibitor of the intracellular signaling kinase tyrosine kinase 2. This phase 1, randomized, partially double-blind, 4-period crossover study in healthy adults was conducted to determine whether deucravacit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ba45e3d729d1150d54b369b8bfcb9b
https://doi.org/10.1002/cpdd.1056
https://doi.org/10.1002/cpdd.1056
Autor:
Kuan‐ju Lin, Shalabh Singhal, Shenita Basdeo, Huadong Sun, John Throup, Hannah Huang, Aberra Fura, Ang Liu, Sebastien Bihorel, Ihab G. Girgis, Elizabeth Ludwig, Diane E. Shevell, Jenny Xie, Santanu Dutta
Publikováno v:
Clinical Pharmacology in Drug Development
Sphingosine‐1‐phosphate (S1P) binding to the S1P‐1 receptor (S1P1R) controls the egress of lymphocytes from lymphoid organs and targets modulation of immune responses in autoimmune diseases. Pharmacologic modulation of S1P receptors has been li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bede4651619c4a35110c650d35f35e3
http://europepmc.org/articles/PMC7821288
http://europepmc.org/articles/PMC7821288
Autor:
Dennis M. Grasela, Ihab G. Girgis, Ang Liu, Miroslawa Nowak, Bing He, Sudeep Kundu, Naiyu Zheng, Ian M. Catlett
Publikováno v:
British Journal of Clinical Pharmacology
Aims Branebrutinib (BMS-986195) is a potent, highly selective, oral, small-molecule, covalent inhibitor of Bruton's tyrosine kinase (BTK). This study evaluated safety, pharmacokinetics and pharmacodynamics of branebrutinib in healthy participants. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6c33c2efaf4d553cd8a056b7d6ab80
http://europepmc.org/articles/PMC7444767
http://europepmc.org/articles/PMC7444767
Autor:
Hongwei Zhang, Weiguo Cai, Ihab G. Girgis, Murli Krishna, Tarek A. Leil, John Throup, Huadong Sun, Leonid Gibiansky, Subhashis Banerjee, Huidong Gu
Publikováno v:
Clinical Pharmacology in Drug Development
BMS‐986184 is a human, second‐generation, anti–interferon‐γ–induced protein 10 (IP‐10) monoclonal antibody. In this study the pharmacokinetics and target engagement (TE) of BMS‐986184 in healthy participants were characterized using po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f07128dd3f6f4904b5d2ce0aab4f250
https://doi.org/10.1002/cpdd.784
https://doi.org/10.1002/cpdd.784